Characteristic | Patients scanned with Aixplorer system (n = 26) |
---|---|
Demographics | |
Men, n (%) | 12 (46) |
Median age, years [IQR] | 40.5 [33.8–44.8] |
Median follow-up after RT, years [IQR] | 7.2 [6.0–10.0] |
Diagnosis, n (%) | |
Carcinoma of parotid | 6 (23) |
Pleiomorphic adenoma of parotid | 8 (31) |
Carcinoma of oropharynx | 2 (8) |
Malignant lymphoma | 7 (27) |
Others | 3 (12) |
Chemotherapy, n (%) | |
Anthracycline | 7 (26) |
Platinum-based | 1 (4) |
Alkylating | 7 (26) |
Other | 1 (4) |
Total | 8 (31) |
Surgery | |
(Partial) parotidectomy | 15 (58) |
Cervical lymph node dissection | 5 (19) |
Partial glossectomy | 2 (8) |
(Hemi)mandibulectomy | 2 (8) |
Other | 2 (8) |
Total | 18 (69) |
CVD risk factors, n (%) | |
Smoking | |
- No | 17 (65) |
- Current | 4 (15) |
- Former | 5 (19) |
- Pack years, median [IQR] | 16.0 (9.5–27.0) |
Positive family history of CVD | 7 (27) |
Chronic daily stress | 8 (31) |
Hypertension | 7 (27) |
Hypercholesterolemia | 8 (38) |
Overweight | 9 (39) |
Diabetes | 1 (4) |
Renal insufficiency | 3 (13) |
Number of CVD risk factors, n (%) | |
0 | 3 (12) |
1 | 6 (23) |
2 | 10 (39) |
≥ 3 | 7 (27) |
Radiation dose, Gy (median [IQR], min–max) | |
Proximal CCA2 | 1 [0–31], 0–553 |
Mid-CCA2 | 4 [1–30], 1–553 |
Distal CCA2 | 22 [8–39], 1–55 |
ICA2 | 43 [29–52], 1–59 |
Total applied to the neck | 50 [38–66], 30–1001 |